Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis

Bladder cancer (BCa) is one of the most common malignancies and has a relatively poor outcome worldwide. However, the molecular mechanisms and processes of BCa development and progression remain poorly understood. Therefore, the present study aimed to identify candidate genes in the carcinogenesis a...

Full description

Bibliographic Details
Main Authors: Chuan Zhang, Mandy Berndt-Paetz, Jochen Neuhaus
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/10/2/66
_version_ 1817992677290934272
author Chuan Zhang
Mandy Berndt-Paetz
Jochen Neuhaus
author_facet Chuan Zhang
Mandy Berndt-Paetz
Jochen Neuhaus
author_sort Chuan Zhang
collection DOAJ
description Bladder cancer (BCa) is one of the most common malignancies and has a relatively poor outcome worldwide. However, the molecular mechanisms and processes of BCa development and progression remain poorly understood. Therefore, the present study aimed to identify candidate genes in the carcinogenesis and progression of BCa. Five GEO datasets and TCGA-BLCA datasets were analyzed by statistical software R, FUNRICH, Cytoscape, and online instruments to identify differentially expressed genes (DEGs), to construct protein‒protein interaction networks (PPIs) and perform functional enrichment analysis and survival analyses. In total, we found 418 DEGs. We found 14 hub genes, and gene ontology (GO) analysis revealed DEG enrichment in networks and pathways related to cell cycle and proliferation, but also in cell movement, receptor signaling, and viral carcinogenesis. Compared with noncancerous tissues, TPM1, CRYAB, and CASQ2 were significantly downregulated in BCa, and the other hub genes were significant upregulated. Furthermore, MAD2L1 and CASQ2 potentially play a pivotal role in lymph nodal metastasis. CRYAB and CASQ2 were both significantly correlated with overall survival (OS) and disease-free survival (DFS). The present study highlights an up to now unrecognized possible role of CASQ2 in cancer (BCa). Furthermore, CRYAB has never been described in BCa, but our study suggests that it may also be a candidate biomarker in BCa.
first_indexed 2024-04-14T01:29:26Z
format Article
id doaj.art-dcbf874fa23a46ea99f899092376f95a
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-04-14T01:29:26Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-dcbf874fa23a46ea99f899092376f95a2022-12-22T02:20:16ZengMDPI AGDiagnostics2075-44182020-01-011026610.3390/diagnostics10020066diagnostics10020066Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics AnalysisChuan Zhang0Mandy Berndt-Paetz1Jochen Neuhaus2Department of Urology, University of Leipzig, 04103 Leipzig, GermanyDepartment of Urology, University of Leipzig, 04103 Leipzig, GermanyDepartment of Urology, University of Leipzig, 04103 Leipzig, GermanyBladder cancer (BCa) is one of the most common malignancies and has a relatively poor outcome worldwide. However, the molecular mechanisms and processes of BCa development and progression remain poorly understood. Therefore, the present study aimed to identify candidate genes in the carcinogenesis and progression of BCa. Five GEO datasets and TCGA-BLCA datasets were analyzed by statistical software R, FUNRICH, Cytoscape, and online instruments to identify differentially expressed genes (DEGs), to construct protein‒protein interaction networks (PPIs) and perform functional enrichment analysis and survival analyses. In total, we found 418 DEGs. We found 14 hub genes, and gene ontology (GO) analysis revealed DEG enrichment in networks and pathways related to cell cycle and proliferation, but also in cell movement, receptor signaling, and viral carcinogenesis. Compared with noncancerous tissues, TPM1, CRYAB, and CASQ2 were significantly downregulated in BCa, and the other hub genes were significant upregulated. Furthermore, MAD2L1 and CASQ2 potentially play a pivotal role in lymph nodal metastasis. CRYAB and CASQ2 were both significantly correlated with overall survival (OS) and disease-free survival (DFS). The present study highlights an up to now unrecognized possible role of CASQ2 in cancer (BCa). Furthermore, CRYAB has never been described in BCa, but our study suggests that it may also be a candidate biomarker in BCa.https://www.mdpi.com/2075-4418/10/2/66bladder cancerbioinformatics analysisdifferentially expressed genestcga-blca databasegeo databases
spellingShingle Chuan Zhang
Mandy Berndt-Paetz
Jochen Neuhaus
Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis
Diagnostics
bladder cancer
bioinformatics analysis
differentially expressed genes
tcga-blca database
geo databases
title Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis
title_full Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis
title_fullStr Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis
title_full_unstemmed Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis
title_short Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis
title_sort identification of key biomarkers in bladder cancer evidence from a bioinformatics analysis
topic bladder cancer
bioinformatics analysis
differentially expressed genes
tcga-blca database
geo databases
url https://www.mdpi.com/2075-4418/10/2/66
work_keys_str_mv AT chuanzhang identificationofkeybiomarkersinbladdercancerevidencefromabioinformaticsanalysis
AT mandyberndtpaetz identificationofkeybiomarkersinbladdercancerevidencefromabioinformaticsanalysis
AT jochenneuhaus identificationofkeybiomarkersinbladdercancerevidencefromabioinformaticsanalysis